NUK - logo
E-resources
Full text
Peer reviewed
  • Intermediate-Term Outcomes ...
    Kumar, Kris; Morris, Craig C.; Samhan, Ashraf; Herman, Tessa; Chau, Trisha; Lantz, Gurion; Chadderdon, Scott M.; Song, Howard K.; Zahr, Firas E.; Golwala, Harsh

    The American journal of cardiology, 03/2022, Volume: 167
    Journal Article

    Patients with a history of chronic lung disease requiring supplemental home oxygen have a higher risk for morbidity and mortality related to surgical aortic valve replacement (SAVR) in a setting of severe aortic stenosis (AS).1 Furthermore, trials assessing transcatheter aortic valve implantation (TAVI) versus SAVR excluded this subgroup. ...it shows that TAVI demonstrates similar all-cause mortality in patients with supplemental home oxygen use compared with those without. ...despite the overall higher STS risk for valvular intervention in severe AS in patients with home oxygen use than those without, the intermediate-term mortality risk and clinical outcomes following TAVI are comparable in the 2 groups.